HeartSciences (HSCS) Cash from Investing Activities (2022 - 2026)
HeartSciences (HSCS) reported Cash from Investing Activities of -$27868.0 for Q1 2026, down 77.49% on a YoY basis from -$123813.1 in Q1 2025, and down 76.72% quarter-over-quarter from -$15770.0 in Q4 2025.
HeartSciences (HSCS) Cash from Investing Activities (2022 - 2026) Analysis & Trends
HeartSciences has reported Cash from Investing Activities for 5 years, with the latest figure at -$27868.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 77.49% year-over-year to -$27868.0; the trailing twelve-month figure through Jan 2026 stood at -$52264.0 (up 42.95% YoY), and the FY2025 full-year result was -$30188.0, up 75.9% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$27868.0, down from -$15770.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$814.0 in Q3 2025, with the low at -$69228.0 in Q2 2024.
- Historically, Cash from Investing Activities has averaged -$15587.1 across 5 years, with a median of -$7419.5 in 2022.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities slumped 1317.73% — and 2025, when it jumped 88.72%.
- HeartSciences' Cash from Investing Activities stood at -$7247.0 in 2022, then soared by 73.06% to -$1952.0 in 2023, then tumbled by 199.28% to -$5842.0 in 2024, then tumbled by 169.94% to -$15770.0 in 2025, then sank by 76.72% to -$27868.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$27868.0 (Q1 2026), -$15770.0 (Q4 2025), and -$814.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - | -27,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -27,868.00 |
| Jan 31, 2026 | -27,868.00 |
| Oct 31, 2025 | -15,770.00 |
| Oct 31, 2025 | -15,770.00 |
| Jul 31, 2025 | -814.00 |
| Jul 31, 2025 | -814.00 |
| Apr 30, 2025 | -7,812.00 |
| Apr 30, 2025 | -7,812.00 |
| Jan 31, 2025 | -15,701.00 |
| Jan 31, 2025 | -15,701.00 |
| Oct 31, 2024 | -5,842.00 |
| Oct 31, 2024 | -5,842.00 |
| Jul 31, 2024 | -833.00 |
| Jul 31, 2024 | -833.00 |
| Apr 30, 2024 | -69,228.00 |
| Apr 30, 2024 | -69,228.00 |
| Jan 31, 2024 | -49,181.00 |
| Jan 31, 2024 | -49,181.00 |
| Oct 31, 2023 | -1,952.00 |
| Oct 31, 2023 | -1,952.00 |